Effective Treatment of Pure Akinesia with L-threo-3,4-Dihydroxyphenylserine (DOPS)
- 1 December 1985
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 8 (4) , 334-342
- https://doi.org/10.1097/00002826-198512000-00004
Abstract
A patient with pure akinesia, who experienced freezing only when starting to walk backward or when turning, is reported. L-DOPA, maprotiline, clonazepam, DL-threo-3,4-dihydroxyphenylserine (DOPS), and L-threo-DOPS were administered to the patient. Only DL-threo-DOPS and L-threo-DOPS were effective, but they concurrently brought on a hypomanic state. Combining carbidopa with DL (or L)-threo-DOPS did not change the effectiveness of the treatment. DL (or L)-threo-DOPS did not affect monoamine metabolites in the cerebrospinal fluid (CSF). The effectiveness of L-threo-DOPS on freezing, the induction of affective changes, and the absence of 3-methoxy-4-hydroxyphenylglycol alteration in the CSF suggest that L-threo-DOPS acts centrally but may not directly involve the noradrenergic system.Keywords
This publication has 0 references indexed in Scilit: